Chapter 1. Preface


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global rat model market, 2015 - 2021, (USD Million)

2.2. Rat model: Market snapshot

Chapter 3. Rat model Market: Market Dynamics


3.1. Rat model: Market dynamics

3.2. Market Drivers


3.2.1. Continuous research undertaken to develop treatments for cancer and neurology disorders.

3.2.2. Emergence of transgenic rat models

3.3. Restraints


3.3.1. Advancement in zebrafish models

3.4. Opportunity


3.4.1. Initiative of government for investments and grants

3.5. Porters Five Forces Analysis

3.6. Market Attractiveness Analysis


3.6.1. Market attractiveness analysis by rat type segment

3.6.2. Market attractiveness analysis by technology segment

3.6.3. Market attractiveness analysis by service segment

3.6.4. Market attractiveness analysis by application segment

3.6.5. Market attractiveness analysis by regional segment

Chapter 4. Global Rat model Market: Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global rat model market: company market share, 2015

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Product Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Product and Regional Expansion

4.3. Product Portfolio

Chapter 5. Global Rat model Market: Rat Type Segment Overview


5.1. Global rat model market share, by rat type, 2015 and 2021



5.2. Global rat model market for outbred , 2015 - 2021(USD Million)

5.3. Global rat model market for conditioned, 2015 - 2021 (USD Million)

5.4. Global rat model market for knockout, 2015 - 2021 (USD Million)

5.5. Global rat model market for others, 2015  2021 (USD Million)

Chapter 6. Global Rat model Market: Technology Segment Overview


6.1. Global rat model market share, by technology, 2015 and 2021

6.2. Global rat model market for embryonic stem cells , 2015 - 2021(USD Million)

6.3. Global rat model market for microinjection, 2015 - 2021 (USD Million)

6.4. Global rat model market for others, 2015  2021 (USD Million)

Chapter 7. Global Rat model Market: Service Segment Overview


7.1. Global rat model market share, by service, 2015 and 2021

7.2. Global rat model market for breeding , 2015 - 2021(USD Million)

7.3. Global rat model market for quarantine, 2015 - 2021 (USD Million)

7.4. Global rat model market for cryopreservation, 2015 - 2021 (USD Million)

7.5. Global rat model market for others, 2015  2021 (USD Million)

Chapter 8. Global Rat model Market: Application Segment Overview


8.1. Global rat model market share, by application, 2015 and 2021

8.2. Global rat model market for toxicology , 2015 - 2021(USD Million)

8.3. Global rat model market for CNS, 2015 - 2021 (USD Million)

8.4. Global rat model market for oncology, 2015 - 2021 (USD Million)

8.5. Global rat model market for immunology and inflammation, 2015 - 2021 (USD Million)

8.6. Global rat model market for diabetes, 2015 - 2021 (USD Million)

8.7. Global rat model market for others, 2015  2021 (USD Million)

Chapter 9. Global Rat model Market: Regional Analysis


9.1. Global rat model market: Regional overview


9.1.1. Global rat model market share, by region, 2015 and 2021

9.2. North America


9.2.1. North America rat model market revenue, by rat type, 2015  2021 (USD Million)

9.2.2. North America rat model market revenue, by technology, 2015  2021 (USD Million)

9.2.3. North America rat model market revenue, by service, 2015  2021 (USD Million)

9.2.4. North America rat model market revenue, by application, 2015  2021 (USD Million)

9.3. Europe


9.3.1. Europe rat model market revenue, by rat type, 2015  2021 (USD Million)

9.3.2. Europe rat model market revenue, by technology, 2015  2021 (USD Million)

9.3.3. Europe rat model market revenue, by service, 2015  2021 (USD Million)

9.3.4. Europe rat model market revenue, by application, 2015  2021 (USD Million)

9.4. Asia Pacific


9.4.1. Asia-Pacific rat model market revenue, by rat type, 2015  2021 (USD Million)

9.4.2. Asia-Pacific rat model market revenue, by technology, 2015  2021 (USD Million)

9.4.3. Asia-Pacific rat model market revenue, by service, 2015  2021 (USD Million)

9.4.4. Asia-Pacific rat model market revenue, by application, 2015  2021 (USD Million)

9.5. Latin America


9.5.1. Latin America rat model market revenue, by rat type, 2015  2021 (USD Million)

9.5.2. Latin America rat model market revenue, by technology, 2015  2021 (USD Million)

9.5.3. Latin America rat model market revenue, by service, 2015  2021 (USD Million)

9.5.4. Latin America rat model market revenue, by application, 2015  2021 (USD Million)

9.6. Middle East  Africa


9.6.1. Middle East  Africa rat model market revenue, by rat type, 2015  2021 (USD Million)

9.6.2. Middle East  Africa rat model market revenue, by technology, 2015  2021 (USD Million)

9.6.3. Middle East  Africa rat model market revenue, by service, 2015  2021 (USD Million)

9.6.4. Middle East  Africa rat model market revenue, by application, 2015  2021 (USD Million)

Chapter 10. Company Profiles


10.1. Covance, Inc.


10.1.1. Overview

10.1.2. Financials

10.1.3. Product portfolio

10.1.4. Business strategy

10.1.5. Recent developments

10.2. Transviragen Inc .


10.2.1. Overview

10.2.2. Financials

10.2.3. Product portfolio

10.2.4. Business strategy

10.2.5. Recent developments

10.3. SAGE Labs


10.3.1. Overview

10.3.2. Financials

10.3.3. Product portfolio

10.3.4. Business strategy

10.3.5. Recent developments

10.4. Biomedical Research Models


10.4.1. Overview

10.4.2. Financials

10.4.3. Product portfolio

10.4.4. Business strategy

10.4.5. Recent developments

10.5. genOway S.A.


10.5.1. Overview

10.5.2. Financials

10.5.3. Product portfolio

10.5.4. Business strategy

10.5.5. Recent developments

10.6. Transposagen Biopharmaceuticals


10.6.1. Overview

10.6.2. Financials

10.6.3. Product portfolio

10.6.4. Business strategy

10.6.5. Recent developments

10.7. Harlan Laboratories


10.7.1. Overview

10.7.2. Financials

10.7.3. Product portfolio

10.7.4. Business strategy

10.7.5. Recent developments

10.8. Charles River Laboratories


10.8.1. Overview

10.8.2. Financials

10.8.3. Product portfolio

10.8.4. Business strategy

10.8.5. Recent developments